AwardedSWEGoodsSEK 30,000,000
Läkemedel Cytostatika 2025
- Published
- Published 13 March 2025
- Deadline
- Closed 10 April 2025
Overview
Läkemedel Cytostatika 2025
Key details
- Country
- SWE
- Status
- Awarded
- Category
- Goods
- Estimated value
- SEK 30,000,000
- Procedure
- Open
- Published
- 13 March 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- SEK 24,450,368
- Award date
- 23 May 2025
- Contract period
- 30 September 2024 → 30 September 2025
- Accord Healthcare AB
- Amgen Aktiebolag
- Baxter Medical Aktiebolag
- Biosimilar Collaborations Ireland Limited
- CAMPUS Pharma AB
- Celltrion Sweden AB
- EQL Pharma AB
- Fresenius Kabi AB
- Glenmark Pharmaceuticals Nordic AB
- Grindeks Kalceks Sverige AB
- Krka Sverige AB
- Orifarm AB
- Orifarm Generics AB
- Pierre Fabre Pharma Norden AB
- Roche Aktiebolag
- STADA Nordic ApS
- Sandoz A/S
- Sun Pharmaceutical Germany Gmbh
- Teva Sweden Aktiebolag
- betapharm Arzneimittel GmbH
- medac
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 October 2025
Contract Notice
13 March 2025
Contracting authority
Region Blekinge
Procuring entityKarlskrona, SWE
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.